Rentiapril

DB20567ExperimentalSmall molecule

Rentiapril is a small molecule drug. The usage of the INN stem '-pril' in the name indicates that Rentiapril is a angiotensin-converting enzyme inhibitor. Rentiapril has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Angiotensin-converting enzyme
Curator reviewed
Formula / weight: C₁₃H₁₅NO₄S₂ · 313.39 g/mol (avg)

Resolves to

Compound

UNIID0TAM1017BCAS80830-42-8ChEMBLCHEMBL309962ChEBI748352PubChem71244

Structure

InChIKeyBSHDUMDXSRLRBI-JOYOIKCWSA-NSMILESOC(=O)[C@@H]1CS[C@@H](N1C(=O)CCS)C1=C(O)C=CC=C1

Targets

P12821ACEQ9HAU8RNPEPL1

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rentiapril, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account